A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

NCT01395940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: KLH-2109
DRUG: KLH-2109

Sponsor

Kissei Pharmaceutical Co., Ltd.